Adial Pharmaceuticals, Inc. Accrued Royalties, Current
Adial Pharmaceuticals, Inc. (ADIL) had Accrued Royalties, Current of $20.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:AccruedRoyaltiesCurrent · last filed 2026-08-14
- 2026-06-30: Accrued Royalties, Current $20.00K.
- 2026-03-31: Accrued Royalties, Current $10.00K.
- 2025-09-30: Accrued Royalties, Current $30.00K.
- 2025-06-30: Accrued Royalties, Current $20.00K.
| Period end | Accrued Royalties, Current |
|---|---|
| 2026-06-30 | $20.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $10.00K 10-Q · filed 2026-05-08 |
| 2025-09-30 | $30.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $20.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $10.00K 10-Q · filed 2025-05-14 |
| 2022-03-31 | $10.00K 10-Q · filed 2022-05-16 |
| 2021-09-30 | $30.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $20.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $10.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $40.00K 10-K · filed 2022-03-28 |
| 2020-09-30 | $30.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $20.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $10.00K 10-Q · filed 2020-05-14 |
| 2019-09-30 | $30.00K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |